Additive effect of brimonidine in maximum tolerated medical therapy for primary open-angle glaucoma
<p> <b>D.A. Dorofeev<sup>1</sup>, V.P. Balukhtina<sup>2</sup>, M.V. Es’kova<sup>1</sup>, K.A. Efimova<sup>1</sup>, E.V. Kirilik<sup>1</sup>, K.O. Luk’yanova<sup>1</sup></b> </p> <p&g...
Saved in:
Main Authors: | D.A. Dorofeev, V.P. Balukhtina, M.V. Es’kova, K.A. Efimova, E.V. Kirilik, K.O. Luk’yanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2021-09-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/0d3/0d300560f5211b902da9abb2243d0ec9.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brimonidine as an additional treatment for moderate glaucoma
by: I.R. Gazizova, et al.
Published: (2021-05-01) -
Modern methods of visualization of the angle of the anterior chamber of the eye in the diagnosis and treatment of glaucoma
by: A.V. Sidorova, et al.
Published: (2022-07-01) -
Ophthalmic risk factors for primary open angle glaucoma
by: V.P. Erichev, et al.
Published: (2019-07-01) -
Systemic risk factors for developing of primary open-angle glaucoma
by: E.A. Egorov, et al.
Published: (2018-09-01) -
Rational pharmacotherapy of primary open-angle glaucoma in elderly and senile patients
by: M.V. Tereshchenko, et al.
Published: (2022-11-01)